Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 10-tom 4-san (2025)
EVALUATION OF THE CLINICAL COURSE OF MYOCARDITIS AND MYOPERICARDITIS IN PATIENTS WITH COVID-19
АХМЕДОВА Гулчехра Абдуллаевна, ШУКУРOВА Дилoрoм Баxoдирoвна
Annotaciya
In December 2019, a new respiratory infection caused by a previously unidentified strain of coronavirus, named SARS-CoV-2, was identified in China. This virus belongs to the Coronaviridae family, Nidovirales, and is characterized by a pleomorphic structure with crown-like spikes on its surface, which is why it was named "coronavirus". The size of the viral particles varies from 80 to 160 nanometers, and the genome length, expressed as positive-sense RNA, ranges from 27 to 32 kilobases. The emergence of SARS-CoV-2 led to a global pandemic, named COVID-19.
коронавирусная болезнь 2019, вирус тяжелого острого респираторного синдрома, скорость оседания эритроцитов, С-реактивный белок, аспартатаминотрансферазаcoronavirus disease 2019, severe acute respiratory syndrome virus, erythrocyte sedimentation rate, C-reactive protein, aspartate aminotransferaseкоронавирус касаллиги 2019, оғир ўткир респиратор синдром вируси, эритроцитларнинг чўкиш тезлиги, C-реактив оқсил, аспартат аминотрансфераза
Metadata derekkózi: jurnal OAI-PMH arxivi · Sindex tolıq mátindi saqlamaydı, derekkózge silteme beredi.